Persistence of Cisplatin-Induced Mutagenicity in Hematopoietic Stem Cells: Implications for Secondary Cancer Risk Following Chemotherapy

Cisplatin is a cytostatic agent used in the treatment of many types of cancer, but its use is associated with increased incidences of secondary leukemia. We evaluated cisplatin's in vivo genotoxic potential by analyzing peripheral blood for Pig-a mutant phenotype erythrocytes and for chromosoma...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Dertinger, Stephen D., Avlasevich, Svetlana L., Torous, Dorothea K., Bemis, Jeffrey C., Phonethepswath, Souk, Labash, Carson, Carlson, Kristine, Mereness, Jared, Cottom, John, Palis, James, MacGregor, James T.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Oxford University Press 2014
Θέματα:
Genetic Toxicology
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4176048/
https://ncbi.nlm.nih.gov/pubmed/24798381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/toxsci/kfu078
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια